Paper Details

  1. Home
  2. Paper Details

Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review.

Author: ChengYuexin, FengJun, HuangYongfen, MiaoYuqing, TangJiao, WangLingling, XuHao

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

Zanubrutinib is a new drug that treats B-cell malignancies. While it's effective, some patients have experienced serious skin reactions. These reactions are rare, but they can be severe and may cause the patient to stop taking the drug.
Paper Details　
Original Abstract of the Article :
Zanubrutinib, a next-generation non-covalent Bruton's tyrosine kinase (BTK) inhibitor, shows great efficacy in the treatment of B cell malignancies. Some patients may experience a series of side effects after the treatment of zanubrutinib. Grade 4 dermatological toxicities are rare, which present as...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359098/

データ提供：米国国立医学図書館（NLM）

Zanubrutinib: A New Oasis in the Desert of B-cell Malignancies, But with Potential Side Effects

Zanubrutinib, a promising new drug for treating B-cell malignancies, is like a refreshing oasis in the desert of cancer research. This drug has shown great efficacy in targeting and destroying these malignancies. However, like any powerful medication, zanubrutinib can come with side effects, including dermatological toxicities. This case report details the experience of three patients who developed severe skin reactions while receiving zanubrutinib treatment. While these side effects are rare, they highlight the need for careful monitoring and prompt intervention. This research emphasizes the importance of balancing the benefits and risks of new therapies.

Navigating the Side Effects of Zanubrutinib: A Careful Approach is Essential

The study highlights the importance of carefully monitoring patients receiving zanubrutinib therapy, especially for potential dermatological toxicities. While these side effects are rare, it's crucial to be aware of them and to take prompt action if they occur. This research underscores the need for a personalized approach to treatment, considering both the benefits and risks of new therapies.

Zanubrutinib: A Promising Drug with Potential Side Effects

Zanubrutinib offers hope for patients with B-cell malignancies, but it's important to be aware of its potential side effects. This research provides valuable insights for clinicians and patients, emphasizing the need for careful monitoring and prompt intervention if necessary. It's a reminder that even in the desert of cancer research, there are always new challenges to navigate.

Dr. Camel's Conclusion

Zanubrutinib is a powerful new drug, but like any powerful tool, it comes with its own set of risks. This research reminds us of the importance of understanding these risks and navigating the treatment landscape carefully to ensure the best possible outcomes for patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-08-13
Further Info :

Pubmed ID

35957865

DOI: Digital Object Identifier

PMC9359098

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.